COX-2 Inhibition, H. pylori Infection and the Risk of Gastrointestinal Complications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|27|2213-2219

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.27, 2003-10, pp. : 2213-2219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2253-2266

Bentham Science Publishers

Access to resources Recommend Favorite

Dual COX Inhibition and Upper Gastrointestinal Damage

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2191-2195

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : i-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : ii-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Recommendations for the treatment of H. pylori infection

By  

Inpharma, Vol. 1, Iss. 1220, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite